Abstract:2611 Zebularine, a synthetic analog of cytidine and a potent inhibitor of cytidine deaminase, has recently been identified as a DNA methylation inhibitor. In addition, nude mice with EJ6 bladder cancer xenografts showed induction of p16 expression and reduction of tumor growth following oral zebularine as compared to untreated controls (Cheng et al JNCI 95 p399 2003). We studied the effect of zebularine on mammary tumor growth in MMTV-PyMT transgenic mice which develop mammary tumors within 60 days with 100 percent penetrance. The mice were randomized at 46 days of age into control (n=25) and zebularine treated (n=25) groups, which were given 5 mg/ml of zebularine in drinking water. Tumors were measured twice weekly and the median tumor weight was calculated for each group. We found a significant delay in the occurrence of tumors in both the axillary and inguinal mammary glands in zebularine treated mice as compared to untreated controls. We observed a statistically significant (p = 0.01) reduction in total tumor burden at 94 days of age when the mice were sacrificed. To determine the mechanism of the zebularine tumor effect we examined the histology of the treated and control tumors. After 48 days of drug treatment the tumors were predominantly necrotic compared to the untreated animals and a high apoptotic index was observed as early as 13 days by tunel assay. A negligible level of apoptotic cells was found in tumors from control animals. Although we did not observe induction of p16 levels after 13, 23 and 48 days of zebularine treatment, we did observe induction of p21 expression, suggesting a tissue specific effect on patterns of gene demethylation. Immunoblot analysis showed depletion of DNMT1 and partial depletion of DNMT3b after zebularine treatment. To investigate the effect of zebularine on global gene expression profiles, microarray analyses were performed on tumors that were excised at 13, 23 and 48 days from both treated and untreated mice. This analysis confirmed p21 induction and the absence of p16 induction. In addition, we identified upregulation of four additional methylation regulated genes (1.5 to 2.4 fold increase) as well as a set of candidate cancer genes that may play a role in cell growth and apoptosis. Our results suggest that the pattern of DNA demethylation following zebularine treatment is restricted to specific sets of genes and that cell death and necrosis contribute to the delay in tumor growth observed in mice continuously exposed to the oral intake of the drug.

Zebularine potentiates anti-tumor immunity by inducing tumor immunogenicity and improving antigen processing through cGAS-STING pathway

DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer.

The Dna Methyltransferase Inhibitor Zebularine Induces Mitochondria-Mediated Apoptosis in Gastric Cancer Cells in Vitro and in Vivo

Zingerone Enhances the Antitumor Activity of Attenuated Salmonella-mediated Cancer Immunotherapy by Promoting Tumor Infiltration by Host Immune Cells

Nano‐Regulator Inhibits Tumor Immune Escape via the "Two‐Way Regulation" Epigenetic Therapy Strategy

Combination of Epigenetic Regulation with Gene Therapy-Mediated Immune Checkpoint Blockade Induces Anti-Tumour Effects and Immune Response in Vivo.

Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy

Inhibiting autophagy enhanced mitotic catastrophe-mediated anticancer immune responses by regulating the cGAS-STING pathway

ZnS@BSA Nanoclusters Potentiate Efficacy of Cancer Immunotherapy

Induction of apoptosis in MMTV/PyMT mammary gland tumors with oral zebularine

Tumor microenvironment-responsive manganese-based nano-modulator activate the cGAS-STING pathway to enhance innate immune system response

Tetrahedral DNA Nanostructure with Interferon Stimulatory DNA Delivers Highly Potent Toxins and Activates the Cgas-Sting Pathway for Robust Chemotherapy and Immunotherapy

Enhanced Growth Inhibition by Combined DNA Methylation/hdac Inhibitors in Lung Tumor Cells with Silenced CDKN2A.

DNA Methyltransferase Inhibitors: Catalysts for Antitumour Immune Responses

STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells

Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD-L1

DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis

Tumor Microenvironment-Responsive DNA-based Nanomedicine Triggers Innate Sensing for Enhanced Immunotherapy.

Select EZH2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT:AP-1 signaling

Cancer Immunotherapy Based on Cell Membrane-Coated Nanocomposites Augmenting Cgas/sting Activation by Efferocytosis Blockade

Zinc-c-di-AMP nanoparticles target and suppress tumors via endothelial STING activation and tumor associated macrophage reinvigoration